A 60-Year-Old Woman With Muscle-Invasive Bladder Cancer and a 77-Year-Old Man With Muscle-Invasive Bladder Cancer - Episode 2

Determining Cisplatin Eligibility for Patients with MIBC

Dr Chamie explains how cisplatin eligibility is defined in patients with MIBC and how many patients in his practice receive neoadjuvant cisplatin therapy.

EP. 1: Case 1 Presentation: A 60-Year-Old Woman With Muscle-Invasive Bladder Cancer (MIBC)
Now Viewing
EP. 2: Determining Cisplatin Eligibility for Patients with MIBC
EP. 3: Available Adjuvant Therapy Options for Patients with Stage II or III MIBC After Previous Cystectomy
EP. 4: Communication and Follow-Up Strategies After Referring a Patient with MIBC to Medical Oncology
EP. 5: Case 2 Presentation: A 77-Year-Old Man With MIBC
EP. 6: Unmet Needs and Clinical Challenges in the Management of MIBC
EP. 7: Potential Future Approaches to Neoadjuvant and Adjuvant Immunotherapy for MIBC
EP. 8: Clinical Pearls for Community Urologists Treating Patients with MIBC